Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS)

INR 689.05

(0.15%)

Annual Balance Sheets

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 2.17 Billion 1.94 Billion 1.68 Billion 1.64 Billion 1.46 Billion 1.35 Billion
Total Current Assets 1.99 Billion 1.64 Billion 1.1 Billion 1.2 Billion 949.1 Million 975.58 Million
Cash And Short Term Investments 1.47 Billion 1.14 Billion 472.76 Million 618.82 Million 380.74 Million 385.34 Million
Cash and Cash Equivalents 1.47 Billion 110.53 Million 251.35 Million 586.31 Million 380.74 Million 385.34 Million
Short Term Investments 1.35 Billion 1.03 Billion 221.41 Million 32.5 Million - 309.54 Million
Net Receivables 109.51 Million 208.72 Million 337.66 Million 288.47 Million 266.18 Million 253.91 Million
Inventory 149.97 Million 206.76 Million 297.42 Million 297.24 Million 293.25 Million 326.92 Million
Other Current Assets 253.72 Million 80.7 Million -81 Thousand 228 Thousand 8.92 Million 9.4 Million
Total Non-Current Assets 178.24 Million 303.86 Million 576.77 Million 437.25 Million 520.44 Million 382.25 Million
Net PPE 93.02 Million 242.78 Million 223.72 Million 233.46 Million 239.63 Million 235.05 Million
Good Will And Intangible Assets -22.5 Million -410 Thousand 23.75 Million 23.75 Million 23.75 Million 20.92 Million
Good Will - - 300 Thousand 300 Thousand 300 Thousand 300 Thousand
Intangible Assets - - 23.45 Million 23.45 Million 23.45 Million 20.62 Million
Long-Term Investments 51.7 Million 33.84 Million 290.55 Million 120.58 Million 113.86 Million 5000.00
Tax Assets 22.5 Million 410 Thousand 9.51 Million 21.1 Million 496.99 Million 126.27 Million
Other Non Current Assets 33.52 Million 27.24 Million 29.22 Million 38.34 Million -353.8 Million -2000.00
Other Assets - - - - - -
Total Liabilities 296.76 Million 360.56 Million 375.99 Million 422.73 Million 359.21 Million 313.11 Million
Total Current Liabilities 191.28 Million 275.71 Million 341.55 Million 403.96 Million 328.29 Million 281.91 Million
Account Payables 75.96 Million 163.63 Million 162.86 Million 180.49 Million 117.09 Million 118.6 Million
Tax Payables - 192 Thousand 79.61 Million 38.21 Million 9.07 Million 11.25 Million
Short Term Debt 13.84 Million 7.54 Million - 67.87 Million 46.64 Million 37.85 Million
Deferred Revenue 74.66 Million 81.38 Million - 137.48 Million 92.07 Million 80.72 Million
Other Current Liabilities 26.82 Million 23.15 Million 178.69 Million 18.1 Million 72.48 Million 44.73 Million
Total Non Current Liabilities 105.48 Million 84.84 Million 34.43 Million 18.76 Million 30.91 Million 31.19 Million
Long-Term Debt 75.57 Million 52.47 Million - 180 Thousand - -
Deferred Revenue Non Current - - - -37.35 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 9.18 Million 10.75 Million 12.56 Million 37.35 Million - -
Other Liabilities - - - - - -
Total Equity 1.87 Billion 1.58 Billion 1.3 Billion 1.21 Billion 1.11 Billion 1.04 Billion
Stock Holders Equity 1.87 Billion 1.58 Billion 1.3 Billion 1.21 Billion 1.11 Billion 1.04 Billion
Common Stock 132.19 Million 130.99 Million 130.99 Million 130.99 Million 130.99 Million 130.99 Million
Retained Earnings 1.04 Billion 945.37 Million 675.15 Million 585.88 Million 476.93 Million 411.32 Million
Accumulated other comprehensive income 1.74 Billion 506.53 Million 496.89 Million 1.08 Billion -337.36 Million -333.59 Million
Common Stock Equity 1.87 Billion 1.58 Billion 1.3 Billion 1.21 Billion 1.11 Billion 1.04 Billion
Capital Lease Obligation 75.57 Million 60.01 Million 52.47 Million - - -
Total Investments 51.7 Million 37.64 Million 205.75 Million 120.58 Million 113.86 Million 5000.00
Total Debt 89.41 Million 60.01 Million - 67.87 Million 46.64 Million 37.85 Million
Net Debt -1.38 Billion -50.51 Million -251.35 Million -518.43 Million -334.09 Million -347.49 Million

Balance Sheet Charts